secwatch.observer — SEC 8-K summary
======================================

Issuer:     RELMADA THERAPEUTICS, INC. (RLMD)
CIK:        0001553643
Form:       8-K
Filed at:   2026-05-28T20:59:47+00:00
Accession:  0001213900-26-062184
Event type: other
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Relmada increases authorized common shares to 200M; stockholders approve 2021 Plan amendment
--------------------------------------------------------------------------------

- Authorized shares increased from 150M to 200M via charter amendment filed May 28, 2026.
- Annual meeting held May 27: 63.5% of eligible shares voted; directors Casamento and Traversa elected.
- Stockholders ratified CBIZ CPAs P.C. as auditor for FY 2026.
- 2021 Equity Incentive Plan amended to increase available shares by 3M to 18,052,942 total.
- Proposals 1-4 all approved; no material dissent on auditor or charter amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1553643/000121390026062184/0001213900-26-062184-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1553643/000121390026062184/ea0292521-8k_relmada.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-062184

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer